Aims Monitoring drug safety in real‐world settings is the primary aim of pharmacovigilance.
Frequent adverse drug reactions (ADRs) are usually identified during drug development …

Antiplatelet therapy is the cornerstone of antithrombotic prevention in patients with
established atherosclerosis, since it has been proven to reduce coronary, cerebrovascular …

Although immunotherapy is expanding treatment options for cancer patients, the prognosis
of advanced cancer remains poor, and these patients must contend with both cancers and …

Acute ischemic stroke (AIS) is the second leading cause of death worldwide. This study aims
at assessing platelet morphology, ultrastructure and function changes of platelets in acute …

Background and objectives Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive
disorder caused by pathogenic variants in the ABCC6 gene. The phenotypic spectrum of …

Previous studies have shown that ticagrelor reduced risk of pneumonia in patients with
acute coronary syndrome (ACS) compared to clopidogrel, however, its effect in patients with …

Purpose Cilostazol is a widely used antiplatelet drug for secondary stroke prevention in
Asia, but its comparison with clopidogrel is not well understood. This study aims to …

The Galilee region of Israel boasts a rich ethnic diversity within its Arab population,
encompassing distinct Muslim, Christian, Druze, and Bedouin communities. This preliminary …

Background Anemia is a global health concern, particularly among the elderly on chronic
antithrombotic treatment. Close monitoring of hemoglobin (Hb) levels and achievement of an …

Purpose To investigate the safety and efficacy of baseline antiplatelet treatment in patients
with acute ischemic stroke (AIS) undergoing mechanical thrombectomy (MT). Materials and …